X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-05-24 | VERO | Hollmig Stanley Tyler | Dir | P - Purchase | $0.64 | +40,000 | 40,000 | New | +$25,720 | ||||||
2022-05-20 | VERO | Serafino Domenic | CEO | P - Purchase | $0.75 | +65,000 | 949,344 | +7% | +$48,750 | ||||||
2022-05-17 | VERO | Portaro Ross | Pres Global Sales | P - Purchase | $0.85 | +10,000 | 60,000 | +20% | +$8,500 | ||||||
2021-12-16 | VERO | Portaro Ross | Pres Global Sales | P - Purchase | $1.35 | +20,000 | 50,000 | +67% | +$27,000 | ||||||
2021-12-15 | VERO | Ew Healthcare Partners, L.P. | 10% | P - Purchase | $1.25 | +3,920,000 | 32,043,822 | +14% | +$4,900,000 | ||||||
2021-12-15 | VERO | Barry Richard Scott | Dir, 10% | P - Purchase | $1.25 | +3,920,000 | 16,337,856 | +32% | +$4,900,000 | ||||||
2021-12-15 | VERO | Healthquest Partners Ii, L.P. | 10% | P - Purchase | $1.25 | +1,600,000 | 6,795,621 | +31% | +$2,000,000 | ||||||
2021-12-15 | VERO | Sullivan Keith J | Dir | P - Purchase | $1.25 | +80,000 | 124,133 | +181% | +$100,000 | ||||||
2021-12-15 | VERO | Kong Garheng | Dir, 10% | P - Purchase | $1.25 | +1,600,000 | 6,795,621 | +31% | +$2,000,000 | ||||||
2021-12-03 | VERO | Portaro Ross | Pres Global Sales | P - Purchase | $1.35 | +30,000 | 30,000 | New | +$40,500 | ||||||
2021-12-01 | VERO | Serafino Domenic | CEO | P - Purchase | $1.32 | +37,500 | 884,344 | +4% | +$49,583 | ||||||
2021-11-19 | VERO | Serafino Domenic | CEO | P - Purchase | $1.48 | +17,000 | 846,844 | +2% | +$25,111 | ||||||
2021-11-17 | VERO | Serafino Domenic | CEO | P - Purchase | $1.60 | +15,500 | 829,844 | +2% | +$24,812 | ||||||
2021-08-18 | VERO | Iger Yoni | VP, RA, QA, Clinical Affairs | P - Purchase | $1.94 | +5,181 | 5,181 | New | +$10,051 | ||||||
2021-07-12 | VERO | Sedco Capital Cayman Ltd | 10% | S - Sale | $3.25 | -50,000 | 922,456 | -5% | -$162,563 | ||||||
2021-07-09 | VERO | Sedco Capital Cayman Ltd | 10% | S - Sale | $3.25 | -57,933 | 972,456 | -6% | -$188,315 | ||||||
2021-07-08 | VERO | Sedco Capital Cayman Ltd | 10% | S - Sale | $3.20 | -100,000 | 1,030,389 | -9% | -$320,270 | ||||||
| M | 2021-07-01 | VERO | Sedco Capital Cayman Ltd | 10% | S - Sale | $3.20 | -46,298 | 1,130,389 | -4% | -$148,154 | |||||
2021-06-28 | VERO | Sedco Capital Cayman Ltd | 10% | S - Sale | $3.20 | -16,646 | 1,176,687 | -1% | -$53,267 | ||||||
2021-06-15 | VERO | Della Penna Domenic | CFO | P - Purchase | $2.41 | +40,000 | 66,663 | +150% | +$96,218 | ||||||
2021-06-14 | VERO | Serafino Domenic | CEO | P - Purchase | $2.46 | +40,000 | 814,344 | +5% | +$98,244 | ||||||
2021-06-01 | VERO | Zaring Chad A | CCO | P - Purchase | $2.09 | +40,000 | 80,000 | +100% | +$83,600 | ||||||
| M | 2020-08-21 | VERO | Zaring Chad A | Chief Commercial Officer | P - Purchase | $2.72 | +40,000 | 40,000 | New | +$108,969 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |